+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alpha Glucosidase Inhibitors"

From
Miglitol Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Miglitol Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Acarbose Oral Preparation Market - Global Forecast 2025-2030 - Product Thumbnail Image

Acarbose Oral Preparation Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Miglitol API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Miglitol API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 191 Pages
  • Global
From
Oral Anti-Diabetic Drugs - Global Strategic Business Report - Product Thumbnail Image

Oral Anti-Diabetic Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 197 Pages
  • Global
From
Diabetes Care Drugs Market Report 2025 - Product Thumbnail Image

Diabetes Care Drugs Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Diabetes Therapeutics Market Report 2025 - Product Thumbnail Image

Diabetes Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Oral Antidiabetic Drugs Market Report 2025 - Product Thumbnail Image

Oral Antidiabetic Drugs Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Non-Insulin Therapies for Diabetes Market Report 2025 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Antidiabetics Market Report 2025 - Product Thumbnail Image

Antidiabetics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Type 2 Diabetes Market Report 2025 - Product Thumbnail Image

Type 2 Diabetes Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Anti-Diabetic Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anti-Diabetic Drug Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 140 Pages
  • Global
From
Type 2 Diabetes Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Type 2 Diabetes Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
From
Loading Indicator

Alpha Glucosidase Inhibitors are a class of drugs used to treat Endocrine and Metabolic Disorders. These drugs work by inhibiting the enzyme alpha-glucosidase, which is responsible for breaking down carbohydrates in the small intestine. This helps to reduce the amount of glucose absorbed into the bloodstream, which can help to control blood sugar levels. Alpha Glucosidase Inhibitors are commonly used to treat type 2 diabetes, as well as other conditions such as polycystic ovary syndrome and gestational diabetes. Alpha Glucosidase Inhibitors are available in both oral and injectable forms. Common side effects of these drugs include abdominal pain, nausea, and diarrhea. Long-term use of these drugs can also lead to an increased risk of hypoglycemia. Some companies that produce Alpha Glucosidase Inhibitors include Novo Nordisk, Sanofi, Eli Lilly, and Merck. Show Less Read more